Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Krill, Kenneth T ^a   Csencsits Smith, Keri ^b   Wood, Sherri C ^a   Faust, Susan ^a   Lu, Guanyi ^a   Bishop, D Keith ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; TNFRSF18 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARDIAC ALLOGRAFT; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; HEART GRAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; WILD TYPE; ALLOTRANSPLANTATION; ANIMAL; CELL DIFFERENTIATION; CYTOTOXIC T LYMPHOCYTE; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; TH2 CELL; AGONISTS; ANTAGONISTS AND INHIBITORS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD40 LIGAND; CELL DIFFERENTIATION; CELL PROLIFERATION; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877269570     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/986859     Document Type: Article

References (39)

1. Nathan M. J., Yin D., Eichwald E. J., Bishop D. K., The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. American Journal of Transplantation 2002 2 4 323 332 2-s2.0-0036556150 10.1034/j.1600-6143.2002. 20406.x (Pubitemid 36306898)
2. Larsen C. P., Elwood E. T., Alexander D. Z., Ritchle S. C., Hendrix R., Tucker-Burden C., Cho H. R., Aruffo A., Hollenbaugh D., Linsley P. S., Winn K. J., Pearson T. C., Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996 381 6581 434 438 2-s2.0-15844404353 10.1038/381434a0 (Pubitemid 26162734)
3. Nathan M. J., Mold J. E., Wood S. C., Csenesits K., Lu G., Eichwald E. J., Bishop D. K., Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells. Journal of Immunology 2004 172 11 6626 6633 2-s2.0-2442691652 (Pubitemid 38669097)
4. Coenen J. J. A., Koenen H. J. P. M., van Rijssen E., Hilbrands L. B., Joosten I., Tolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cells. Transplantation 2005 79 2 147 156 2-s2.0-12744269337 10.1097/01.TP.0000147460.93587.87
5. Li X. C., Rothstein D. M., Sayegh M. H., Costimulatory pathways in transplantation: challenges and new developments. Immunological Reviews 2009 229 1 271 293 2-s2.0-65349189555 10.1111/j.1600-065X.2009.00781.x
6. Adams A. B., Pearson T. C., Larsen C. P., Heterologous immunity: an overlooked barrier to tolerance. Immunological Reviews 2003 196 147 160 2-s2.0-0344553377 10.1046/j.1600-065X.2003.00082.x (Pubitemid 37468109)
7. Demirci G., Amanullah F., Kewalaramani R., Yagita H., Strom T. B., Sayegh M. H., Li X. C., Critical role of OX40 in CD28 and CD154-independent rejection. Journal of Immunology 2004 172 3 1691 1698 2-s2.0-1642485023 (Pubitemid 38116817)
8. Williams M. A., Trambley J., Ha J., Adams A. B., Durham M. M., Rees P., Cowan S. R., Pearson T. C., Larsen C. P., Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. Journal of Immunology 2000 165 12 6849 6857 2-s2.0-0034671978 (Pubitemid 32001153)
9. Burrell B. E., Lu G., Li X. C., Bishop D. K., OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. Journal of Immunology 2009 182 1 379 390 2-s2.0-59849096875
10. Nocentini G., Riccardi C., Grewal I., GITR: a modulator of immune response and inflammation. Therapeutic Targets of the TNF Superfamily 2009 647 New York, NY, USA Springer 156 173
11. Nocentini G., Ronchetti S., Cuzzocrea S., Riccardi C., GITR/GITRL: more than an effector T cell co-stimulatory system. European Journal of Immunology 2007 37 5 1165 1169 2-s2.0-34250341733 10.1002/eji.200636933 (Pubitemid 46925300)
12. Kohm A. P., Podojil J. R., Williams J. S., McMahon J. S., Miller S. D., CD28 regulates glucocorticoid-induced TNF receptor family-related gene expression on CD4+ T cells via IL-2-dependent mechanisms. Cellular Immunology 2005 235 1 56 64 2-s2.0-26944441239 10.1016/j.cellimm.2005.07.002 (Pubitemid 41483034)
13. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S., Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunology 2002 3 2 135 142 2-s2.0-0036170938 10.1038/ni759 (Pubitemid 34141443)
14. Shevach E. M., Stephens G. L., Opinion: the GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nature Reviews Immunology 2006 6 8 613 618 2-s2.0-33746575650 10.1038/nri1867 (Pubitemid 44134094)
15. Kanamaru F., Youngnak P., Hashiguchi M., Nishioka T., Takahashi T., Sakaguchi S., Ishikawa I., Azuma M., Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. Journal of Immunology 2004 172 12 7306 7314 2-s2.0-2942532501 (Pubitemid 38747590)
16. Cuzzocrea S., Nocentini G., Di Paola R., Agostini M., Mazzon E., Ronchetti S., Crisafulli C., Esposito E., Caputi A. P., Riccardi C., Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. Journal of Immunology 2006 177 1 631 641 2-s2.0-33745293611 (Pubitemid 43939177)
17. Santucci L., Agostini M., Bruscoli S., Mencarelli A., Ronchetti S., Ayroldi E., Morelli A., Baldoni M., Riccardi C., GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 2007 56 1 52 60 2-s2.0-33846011898 10.1136/gut.2006.091181 (Pubitemid 46044889)
18. Suvas S., Kim B., Sarangi P. P., Tone M., Waldmann H., Rouse B. T., In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. Journal of Virology 2005 79 18 11935 11942 2-s2.0-24644515759 10.1128/JVI.79.18.11935-11942.2005 (Pubitemid 41279310)
19. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Weiner H. L., Kuchroo V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 7090 235 238 2-s2.0-33646577466 10.1038/nature04753
20. Corry R. J., Winn H. J., Russell P. S., Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non H-2 antigens in rejection. Transplantation 1973 16 4 343 350 2-s2.0-0015866545
21. Matesic D., Lehmann P. V., Heeger P. S., High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998 65 7 906 914 2-s2.0-0032522536 10.1097/00007890-199804150- 00008 (Pubitemid 28201441)
22. Liu Z., Tian S., Falo L. D. Jr., Sakaguchi S., You Z., Therapeutic immunity by adoptive tumor-primed CD4+ T-cell transfer in combination with in vivo GITR ligation. Molecular Therapy 2009 17 7 1274 1281 2-s2.0-67649875392 10.1038/mt.2009.100
23. Bluestone J. A., Abbas A. K., Natural versus adaptive regulatory T cells. Nature Reviews Immunology 2003 3 3 253 257 2-s2.0-0037364804 10.1038/nri1032 (Pubitemid 37323210)
24. Horwitz D. A., Zheng S. G., Gray J. D., Natural and TGF- β -induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other. Trends in Immunology 2008 29 9 429 435 2-s2.0-49849094011 10.1016/j.it.2008.06.005
25. Csencsits K. L., Bishop D. K., Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction. American Journal of Transplantation 2003 3 2 107 115 2-s2.0-0037295673 10.1034/j.1600-6143.2003. 00036.x (Pubitemid 36329127)
26. Chan S. Y., DeBruyne L. A., Goodman R. E., Eichwald E. J., Bishop D. K., In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995 59 8 1155 1161 2-s2.0-0029049485
27. Goldman M., le Moine A., Braun M., Flamand V., Abramowicz D., A role for eosinophils in transplant rejection. Trends in Immunology 2001 22 5 247 251 2-s2.0-0034919643 10.1016/S1471-4906(01)01893-2 (Pubitemid 32667511)
28. Haque A., Stanley A. C., Amante F. H., Rivera F. D. L., Zhou Y., Kuns R. D., Yardley V., Sakaguchi S., Hill G. R., Engwerda C. R., Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. Journal of Immunology 2010 184 5 2583 2592 2-s2.0-77951886063 10.4049/jimmunol.0903080
29. Bushell A., Wood K., GITR ligation blocks allograft protection by induced CD25 +CD4+ regulatory T cells without enhancing effector T-cell function. American Journal of Transplantation 2007 7 4 759 768 2-s2.0-33947667952 10.1111/j.1600-6143.2006.01716.x (Pubitemid 46486618)
30. Sonawane S. B., Kim J. I., Lee M. K., Lee S. H., Duff P. E., Moore D. J., Lian M. M., Deng S., Choi Y., Yeh H., Caton A. J., Markmann J. F., GITR blockade facilitates treg mediated allograft survival. Transplantation 2009 88 10 1169 1177 2-s2.0-73849110532 10.1097/TP.0b013e3181ba6f85
31. Monk N. J., Hargreaves R. E. G., Marsh J. E., Farrar C. A., Sacks S. H., Millrain M., Simpson E., Dyson J., Jurcevic S., Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nature Medicine 2003 9 10 1275 1280 2-s2.0-0142105503 10.1038/nm931 (Pubitemid 37279850)
32. Sánchez-Fueyo A., Domenig C., Strom T. B., Zheng X. X., The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression. Transplantation 2002 74 6 898 900 2-s2.0-0037183940
33. Lee B. O., Haynes L., Eaton S. M., Swain S. L., Randall T. D., The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. Journal of Experimental Medicine 2002 196 5 693 704 2-s2.0-0036717296 10.1084/jem.20020845 (Pubitemid 35024446)
34. Bishop D. K., Wood S. C., Eichwald E. J., Orosz C. G., Immunobiology of allograft rejection in the absence of IFN- γ: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. Journal of Immunology 2001 166 5 3248 3255 2-s2.0-0035284893 (Pubitemid 33117324)
35. Piccotti J. R., Chan S. Y., Goodman R. E., Magram J., Eichwald E. J., Bishop D. K., IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection: evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. Journal of Immunology 1996 157 5 1951 1957 2-s2.0-0030240073 (Pubitemid 126449668)
36. Wood S. C., Lu G., Burrell B. E., Bishop D. K., Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells. American Journal of Transplantation 2008 8 10 2037 2048 2-s2.0-52049110333 10.1111/j.1600-6143.2008.02372.x
37. Graca L., Honey K., Adams E., Cobbold S. P., Waldmann H., Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. Journal of Immunology 2000 165 9 4783 4786 2-s2.0-0034327171
38. Oderup C., Malm H., Ekberg H., Qi Z., Veress B., Ivars F., Corbascio M., Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4+Foxp3+ T cells. Transplantation 2006 82 11 1493 1500 2-s2.0-33845703869 10.1097/01.tp.0000244064.66136.04 (Pubitemid 44967633)
39. van Maurik A., Fazekas de St Groth B., Wood K. J., Jones N. D., Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. Journal of Immunology 2004 172 4 2163 2170 2-s2.0-0842343441 (Pubitemid 38182362)